Pemigatinib 1513857-77-6
ISO COA 4 Inquiries
1513857-77-6
Pharmaceutical Grade
99%
Shanghai
Zentrachem
25kgs in drum
2025-11-30
pharmaceutical intermediates,excipients,plant extracts,food additives,CDMO,fine cheimcals
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceClass: receptor tyrosine kinase; Treatment: metastatic cholangiocarcinoma; Other name: INCB054828; Elimination half-life = 15 h; Protein binding = 90.6%CertificatesBasic Info
-
Product Name:
Pemigatinib
Other Name:Pemigatinib;3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one;INCB-054828;3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholinomethyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one;2H-Pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one, 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-1,3,4,7-tetrahydro-8-(4-morpholinylmethyl)-;IBI-375;3-(2,6-Difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholinomethyl)-1,3,4,6-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one;2H8]-Pemigatinib
CAS No.:1513857-77-6
Molecular Formula:C24H27F2N5O4
InChIKeys:HCDMJFOHIXMBOV-UHFFFAOYSA-N
Molecular Weight:487.5
Color/Form:White to light yellow
Categories:
Characteristics-
Density:
1.44±0.1 g/cm3(Predicted)
Boiling Point:697.6±55.0 °C(Predicted)
PKA:11.56±0.40(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
pharmaceutical intermediates,excipients,plant extracts,food additives,CDMO,fine cheimcals
-
Location:
Rm 301, Bld 2, Taohuahu Neighborhood Center, Hangzhou, China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,100% TT in advance
-
Average lead Time:
14
-
Total Employees:
5-10
-
Year of Establishment:
2025
-
-
Inquiry History4 Inquiries
Country Product Purchase Quantity Date Posted
Pakistan
Pemigatinib
1 MT May 27, 2025
United States
Pemigatinib
180 MG Aug 6, 2026
United States
Pemigatinib
650 MG Aug 1, 2026
United Kingdom
Pemigatinib
1 G May 7, 2026 Post an enquiry for this product